Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignature

Abstract Autosomal dominant CDK13-related disease is characterized by congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD). Heterozygous pathogenic variants, particularly missense variants in the kinase domain, have previously been described as dise...

Full description

Saved in:
Bibliographic Details
Main Authors: Jan Fischer, Mariëlle Alders, Marcel M. A. M. Mannens, David Genevieve, Karl Hackmann, Evelin Schröck, Bekim Sadikovic, Joseph Porrmann
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Clinical Epigenetics
Subjects:
Online Access:https://doi.org/10.1186/s13148-024-01807-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594640281272320
author Jan Fischer
Mariëlle Alders
Marcel M. A. M. Mannens
David Genevieve
Karl Hackmann
Evelin Schröck
Bekim Sadikovic
Joseph Porrmann
author_facet Jan Fischer
Mariëlle Alders
Marcel M. A. M. Mannens
David Genevieve
Karl Hackmann
Evelin Schröck
Bekim Sadikovic
Joseph Porrmann
author_sort Jan Fischer
collection DOAJ
description Abstract Autosomal dominant CDK13-related disease is characterized by congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD). Heterozygous pathogenic variants, particularly missense variants in the kinase domain, have previously been described as disease causing. Using the determination of a methylation pattern and comparison with an established episignature, we reveal the first hypomorphic variant in the kinase domain of CDK13, leading to a never before described autosomal recessive form of CHDFIDD in a boy with characteristic features. This highlights the utility of episignatures in variant interpretation, as well as a potential novel diagnostic approach in unsolved cases or for disease prognosis.
format Article
id doaj-art-a5fedb9c64cf4918b4a228501c828bec
institution Kabale University
issn 1868-7083
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Clinical Epigenetics
spelling doaj-art-a5fedb9c64cf4918b4a228501c828bec2025-01-19T12:27:52ZengBMCClinical Epigenetics1868-70832025-01-011711610.1186/s13148-024-01807-7Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignatureJan Fischer0Mariëlle Alders1Marcel M. A. M. Mannens2David Genevieve3Karl Hackmann4Evelin Schröck5Bekim Sadikovic6Joseph Porrmann7Faculty of Medicine of TUD Dresden University of Technology, Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of TechnologyDepartment of Human Genetics, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of AmsterdamDepartment of Human Genetics, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of AmsterdamGenetic Department, Reference Center for Abnormal Development and Malformative Syndrome, Montpellier University, ERN ITHACA, CHU MontpellierFaculty of Medicine of TUD Dresden University of Technology, Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of TechnologyFaculty of Medicine of TUD Dresden University of Technology, Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of TechnologyVerspeeten Clinical Genome Centre, London Health Sciences CentreFaculty of Medicine of TUD Dresden University of Technology, Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of TechnologyAbstract Autosomal dominant CDK13-related disease is characterized by congenital heart defects, dysmorphic facial features, and intellectual developmental disorder (CHDFIDD). Heterozygous pathogenic variants, particularly missense variants in the kinase domain, have previously been described as disease causing. Using the determination of a methylation pattern and comparison with an established episignature, we reveal the first hypomorphic variant in the kinase domain of CDK13, leading to a never before described autosomal recessive form of CHDFIDD in a boy with characteristic features. This highlights the utility of episignatures in variant interpretation, as well as a potential novel diagnostic approach in unsolved cases or for disease prognosis.https://doi.org/10.1186/s13148-024-01807-7CDK13CHDFIDDDevelopmental delayEpisignature
spellingShingle Jan Fischer
Mariëlle Alders
Marcel M. A. M. Mannens
David Genevieve
Karl Hackmann
Evelin Schröck
Bekim Sadikovic
Joseph Porrmann
Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignature
Clinical Epigenetics
CDK13
CHDFIDD
Developmental delay
Episignature
title Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignature
title_full Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignature
title_fullStr Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignature
title_full_unstemmed Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignature
title_short Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignature
title_sort validation of a hypomorphic variant in cdk13 as the cause of chdfidd with autosomal recessive inheritance through determination of an episignature
topic CDK13
CHDFIDD
Developmental delay
Episignature
url https://doi.org/10.1186/s13148-024-01807-7
work_keys_str_mv AT janfischer validationofahypomorphicvariantincdk13asthecauseofchdfiddwithautosomalrecessiveinheritancethroughdeterminationofanepisignature
AT mariellealders validationofahypomorphicvariantincdk13asthecauseofchdfiddwithautosomalrecessiveinheritancethroughdeterminationofanepisignature
AT marcelmammannens validationofahypomorphicvariantincdk13asthecauseofchdfiddwithautosomalrecessiveinheritancethroughdeterminationofanepisignature
AT davidgenevieve validationofahypomorphicvariantincdk13asthecauseofchdfiddwithautosomalrecessiveinheritancethroughdeterminationofanepisignature
AT karlhackmann validationofahypomorphicvariantincdk13asthecauseofchdfiddwithautosomalrecessiveinheritancethroughdeterminationofanepisignature
AT evelinschrock validationofahypomorphicvariantincdk13asthecauseofchdfiddwithautosomalrecessiveinheritancethroughdeterminationofanepisignature
AT bekimsadikovic validationofahypomorphicvariantincdk13asthecauseofchdfiddwithautosomalrecessiveinheritancethroughdeterminationofanepisignature
AT josephporrmann validationofahypomorphicvariantincdk13asthecauseofchdfiddwithautosomalrecessiveinheritancethroughdeterminationofanepisignature